Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs VanEck Semiconductor ETF (SMH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs VanEck Semiconductor ETF — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.32 (market cap $7.10B), while VanEck Semiconductor ETF trades at $551.98 (market cap $71.21B). The key difference: VanEck Semiconductor ETF is far larger — about 10× Ionis Pharmaceuticals Inc. Common Stock's market cap, and VanEck Semiconductor ETF is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and VanEck Semiconductor ETF for 102 Days on average.
| IONS | SMH | |
|---|---|---|
Market Cap | $7.10B | $71.21B |
Volume | 2,027,457 | 11,805,201 |
Sector | Health | — |
52-Week High | $86.50 | $668.91 |
52-Week Low | $42.38 | $325.10 |
Typical Hold Time | 0 Days | 102 Days |
Enterprise Value | $6.66B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SMH (VanEck Semiconductor ETF) trades at $588.12, down 0.49% on the day, with technical indicators showing mixed signals - a bullish overall signal but bearish moving averages. The semiconductor sector has been a standout performer in 2026, with SMH delivering approximately 69% returns year-to-date according to The Motley Fool (2026-10-01). Recent sector strength is supported by AI-driven demand and major acquisitions like AMD's $8.2 billion World Labs purchase.
The semiconductor ETF offers diversified exposure to the AI hardware boom, though concentration in top holdings like Nvidia presents both opportunity and risk. Sector rotation concerns and valuation pressures after strong gains represent near-term headwinds, while long-term growth prospects remain favorable given Bank of America's projection of near-doubling global chip market by 2030.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About VanEck Semiconductor ETF
The fund normally invests at least 80% of its total assets in securities that comprise the target index. The index includes common stocks and depositary receipts of US exchange-listed companies in the semiconductor industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a US exchange. The fund is non-diversified.
Read more on SMH →
